Company intelligence / Profile preview

OMAPiX

Leuven, Flemish Brabant Province, Belgiumomapix.com ↗

Ownership: Private
Development stage: Other

Overview

OMAPiX provides end-to-end spatial omics services—including spatial transcriptomics and proteomics—enabling deep molecular profiling for pharmaceutical and academic research. Their expertise accelerates biomarker discovery, target identification, disease mechanism elucidation, and supports clinical trial programs in oncology, neurology, rare diseases, and more. They partner with leading technology providers to offer high-throughput data generation at subcellular resolution.

Therapeutic areas: OncologyRare DiseasesNeurology
Modalities: Spatial transcriptomicsProteomics
Industry: Drug Discovery Services

Partnerships

Vizgen (MERSCOPE Platform)Resolve Biosciences (Molecular Cartography™)Ultivue (InSituPlex®)UltiStacker®

Beyond the preview

Go deeper on OMAPiX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OMAPiX.

Explore the full profile